Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Loncar Cancer Immunotherapy ETF (CNCR)

Loncar Cancer Immunotherapy ETF (CNCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Exchange Traded Concepts
  • Assets Under Management 38,601,800
  • Market Capitalization, $K 38,602
  • Shares Outstanding, K 1,650
  • 60-Month Beta 1.72
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.35 (1.49%)
  • Most Recent Dividend 0.350 on 12/28/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.14 +16.91%
on 11/07/19
23.78 -0.99%
on 12/05/19
+3.39 (+16.81%)
since 11/06/19
3-Month
17.82 +32.13%
on 10/02/19
23.78 -0.99%
on 12/05/19
+3.88 (+19.72%)
since 09/06/19
52-Week
16.87 +39.57%
on 12/24/18
23.78 -0.99%
on 12/05/19
+2.61 (+12.44%)
since 12/06/18

Most Recent Stories

More News
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 41.39 (+1.95%)
BBP : 43.58 (+1.46%)
BTEC : 37.70 (+1.19%)
BBH : 141.22 (+1.00%)
XBI : 94.43 (+1.23%)
IBB : 120.03 (+0.98%)
FBT : 149.17 (+0.51%)
CNCR : 23.55 (+0.66%)
PBE : 54.96 (+1.14%)
ARKG : 34.59 (+1.44%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 23.55 (+0.66%)
BBC : 33.25 (+1.55%)
BBP : 43.58 (+1.46%)
GBT : 79.35 (+4.20%)
PTI : 3.55 (-6.33%)
VRTX : 223.25 (+0.08%)
CLVS : 9.61 (+8.47%)
MYOV : 16.61 (-1.01%)
CNST : 43.70 (+2.46%)
KRTX : 67.63 (+3.35%)
CRSP : 72.37 (+2.35%)
ARKG : 34.59 (+1.44%)
GNOM : 16.21 (+1.48%)
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

Healthcare bounced back with an outperformance starting the fourth quarter.

CNCR : 23.55 (+0.66%)
SBIO : 41.39 (+1.95%)
IHF : 196.28 (+0.86%)
BBC : 33.25 (+1.55%)
IRWD : 12.48 (+1.22%)
SEM : 22.98 (+1.50%)
OSMT : 6.51 (-1.06%)
JNCE : 7.79 (+2.43%)
GNOM : 16.21 (+1.48%)
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

PTH : 91.63 (+0.87%)
PBE : 54.96 (+1.14%)
XBI : 94.43 (+1.23%)
CNCR : 23.55 (+0.66%)
DXCM : 224.76 (-0.90%)
CLVS : 9.61 (+8.47%)
BIIB : 300.26 (+0.29%)
PTI : 3.55 (-6.33%)
AQST : 8.01 (-3.96%)
FTSV : 14.44 (+2.12%)
ARKG : 34.59 (+1.44%)
Cancer-Fighting Stocks & ETF: What You Need to Know

Many biotech stocks soared after they presented very promising cancer treatment results at the ASCO conference

BMY : 59.95 (+0.79%)
MRK : 88.85 (+0.11%)
AZN : 47.68 (+0.13%)
CNCR : 23.55 (+0.66%)
CHNA : 24.11 (+0.68%)
NKTR : 20.45 (+2.97%)
IOVA : 24.72 (-0.60%)
Why Cancer-Fighting Stocks & ETFs Are Soaring

The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.

LLY : 119.64 (-0.11%)
AZN : 47.68 (+0.13%)
BMY : 59.95 (+0.79%)
MRK : 88.85 (+0.11%)
CNCR : 23.55 (+0.66%)
CELG : 108.24 (+0.10%)
MRTX : 102.62 (-2.08%)
NKTR : 20.45 (+2.97%)
IOVA : 24.72 (-0.60%)
CHNA : 24.11 (+0.68%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 23.11 (+1.05%)
ITA : 228.68 (+1.08%)
BTEC : 37.70 (+1.19%)
CNCR : 23.55 (+0.66%)
XLP : 62.67 (+0.38%)
GNRX : 22.42 (-0.06%)
BBC : 33.25 (+1.55%)
EWW : 43.00 (-0.49%)
PBW : 31.20 (+1.20%)
XAR : 110.47 (+0.92%)
MOO : 66.50 (+0.71%)
CARZ : 33.69 (+0.73%)
PPA : 68.69 (+0.60%)
IEIH : 27.84 (+0.73%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 23.11 (+1.05%)
ITA : 228.68 (+1.08%)
BTEC : 37.70 (+1.19%)
CNCR : 23.55 (+0.66%)
XLP : 62.67 (+0.38%)
GNRX : 22.42 (-0.06%)
BBC : 33.25 (+1.55%)
EWW : 43.00 (-0.49%)
PBW : 31.20 (+1.20%)
XAR : 110.47 (+0.92%)
MOO : 66.50 (+0.71%)
CARZ : 33.69 (+0.73%)
PPA : 68.69 (+0.60%)
IEIH : 27.84 (+0.73%)
Best and Worst ETFs of Last Week

After a solid comeback, the momentum on the Wall Street cooled down last week given the round of dismal data across the globe, the European Central Bank's surprise move and dismal U.S. jobs data that renewed...

XES : 7.27 (+4.76%)
SCIN : 13.77 (-0.07%)
CNCR : 23.55 (+0.66%)
DWSH : 24.23 (-2.06%)
BDRY : 18.20 (+1.76%)
VXXB : 26.65 (+3.78%)
Best and Worst ETFs of Last Week

After a solid comeback, the momentum on the Wall Street cooled down last week given the round of dismal data across the globe, the European Central Bank's surprise move and dismal U.S. jobs data that renewed...

XES : 7.27 (+4.76%)
SCIN : 13.77 (-0.07%)
CNCR : 23.55 (+0.66%)
DWSH : 24.23 (-2.06%)
BDRY : 18.20 (+1.76%)
VXXB : 26.65 (+3.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CNCR with:

Fund Summary

The Loncar Cancer Immunotherapy ETF seeks investment results that correspond generally to the price and yield per for mance, before fees and expenses, of the Loncar Cancer Immunotherapy Index.

See More

Key Turning Points

2nd Resistance Point 23.76
1st Resistance Point 23.65
Last Price 23.55
1st Support Level 23.48
2nd Support Level 23.42

See More

52-Week High 23.78
Last Price 23.55
Fibonacci 61.8% 21.14
Fibonacci 50% 20.33
Fibonacci 38.2% 19.51
52-Week Low 16.87

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar